NEWS , Press release 2025.10.28  Rebirthel and C4U Entered into a Memorandum of Understanding Aiming for the Collaborative Research

Rebirthel Co., Ltd. and C4U Corporation (“C4U”) are pleased to announce that we have entered into a memorandum of understanding to explore the possibility of collaborative research and development. 

【About C4U】
C4U is promoting the development of novel therapies for various diseases, including genetic diseases, utilizing CRISPR-Cas3, a unique genome editing technology, both in-house and in collaboration with other companies. 

For details, please see the press release below.